Paul Knight
Stock Analyst at Keybanc
(1.87)
# 3,233
Out of 5,154 analysts
140
Total ratings
45.69%
Success rate
-2.58%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STVN Stevanato Group | Maintains: Overweight | $37 → $32 | $15.41 | +107.66% | 6 | Mar 5, 2026 | |
| TMO Thermo Fisher Scientific | Upgrades: Overweight | $750 | $501.97 | +49.41% | 7 | Dec 8, 2025 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $325 → $350 | $245.86 | +42.36% | 12 | Oct 24, 2025 | |
| XGN Exagen | Maintains: Overweight | $12 → $15 | $3.29 | +355.93% | 7 | Oct 14, 2025 | |
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $6.96 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $132.08 | +66.57% | 1 | Sep 4, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $8.09 | +85.41% | 9 | Aug 6, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $0.55 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $53.89 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $302.54 | +52.05% | 5 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $0.99 | - | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $4.12 | +94.17% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $91.34 | +58.75% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $170.13 | +146.87% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $104.25 | +120.62% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $19.86 | +66.16% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $27.12 | +32.74% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $195.50 | +58.57% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $119.99 | +83.35% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.55 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $2.11 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $115.07 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $24.30 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $8.17 | +389.60% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $174.46 | +71.96% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $174.49 | +43.27% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $113.31 | +289.20% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $132.00 | +78.79% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $76.55 | +29.33% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $13.29 | +313.85% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $33.85 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $87.03 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $124.62 | - | 5 | Oct 23, 2017 |
Stevanato Group
Mar 5, 2026
Maintains: Overweight
Price Target: $37 → $32
Current: $15.41
Upside: +107.66%
Thermo Fisher Scientific
Dec 8, 2025
Upgrades: Overweight
Price Target: $750
Current: $501.97
Upside: +49.41%
West Pharmaceutical Services
Oct 24, 2025
Maintains: Overweight
Price Target: $325 → $350
Current: $245.86
Upside: +42.36%
Exagen
Oct 14, 2025
Maintains: Overweight
Price Target: $12 → $15
Current: $3.29
Upside: +355.93%
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $6.96
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $132.08
Upside: +66.57%
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $8.09
Upside: +85.41%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.55
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $53.89
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $302.54
Upside: +52.05%
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.99
Upside: -
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $4.12
Upside: +94.17%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $91.34
Upside: +58.75%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $170.13
Upside: +146.87%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $104.25
Upside: +120.62%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $19.86
Upside: +66.16%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $27.12
Upside: +32.74%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $195.50
Upside: +58.57%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $119.99
Upside: +83.35%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $3.55
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $2.11
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $115.07
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $24.30
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $8.17
Upside: +389.60%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $174.46
Upside: +71.96%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $174.49
Upside: +43.27%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $113.31
Upside: +289.20%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $132.00
Upside: +78.79%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $76.55
Upside: +29.33%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $13.29
Upside: +313.85%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $33.85
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $87.03
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $124.62
Upside: -